Interesting Engineering on MSN14 小时
Sniffing out cancer: Scientists test nasal drug for deadly pancreatic tumors
A groundbreaking approach led by a team of scientists, including Rice University chemist James Tour, has the potential to ...
Scripps News on MSN8 天
FDA approves standalone nasal spray to treat depression
A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.
Medindia3 天
FDA Approves Esketamine Nasal Spray for Resistant Depression
FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...
Monthly Prescribing Reference3 天
Nasal Spray Formulation of Bumetanide Under FDA Review
The NDA is supported by data from a clinical trial that compared the absorption and efficacy of the nasal treatment with oral and IV bumetanide in 68 healthy adults.
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
Nasal spray approved to help treat depression
The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.